Enjoy complimentary customisation on priority with our Enterprise License!
The antihypertensive drugs market share is expected to increase by USD 5.87 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 3.1%.
This antihypertensive drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers antihypertensive drugs market segmentations by type (systemic hypertension and pulmonary hypertension) and geography (North America, Europe, Asia, and Rest of World (ROW)). The antihypertensive drugs market report also offers information on several market vendors, including Abbott Laboratories, AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Co Inc, Bayer AG, Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson, Lupin Ltd, Merck and Co. Inc., Noden Pharma DAC, Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc., and Zydus Lifesciences Ltd. among others.
Download Report Sample to Unlock the Antihypertensive Drugs Market Size for the Forecast Period and Other Important Statistics
The availability of a wide range of drugs is notably driving the antihypertensive drugs market growth, although factors such as the advent of wearable defibrillators may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the antihypertensive drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Antihypertensive Drugs Market Driver
The availability of a wide range of drugs is one of the factors driving the antihypertensive drugs market growth. Patients with hypertension are generally treated with drugs that can reduce blood volume, systemic vascular resistance, and cardiac output by depressing heart rate and stroke volume. For example, diuretic drugs decrease blood volume by increasing urine output by the kidney. Similarly, vasodilator drugs dilate blood vessels through the relaxation of smooth muscle in blood vessels. Hence, the availability of a wide range of therapeutics is offering specific treatment to patients with hypertension and driving the growth of the market during the forecast period.
Key Antihypertensive Drugs Market Trend
The development of modified release formulations is one of the key antihypertensive drugs market trends fueling the market growth. Modified-release formulations are designed to delay the release of drugs in the body after their administration. Some of the modified-release formulations consist of sustained-release and controlled-release formulations. Sustained-release formulations maintain drug release over a sustained period but not at a constant rate, whereas controlled-release formulations maintain drug release over a sustained period at a nearly constant rate. Hence, pharmaceutical companies are developing these formulations for the treatment of hypertension. Thus, the modified-release formulations are expected to enter the market during the forecast period and add significant value to its growth.
Key Antihypertensive Drugs Market Challenge
The advent of wearable defibrillators is one of the factors impeding the antihypertensive drugs market growth. The global antihypertensive drugs market is witnessing increasing R&D efforts for the development of wearable cardiovascular defibrillators for the management of cardiovascular symptoms. Furthermore, studies revealed that the risk of stroke was reduced to half in patients who received the previous generation HeartMate II pump, which required an abdominal location for the implant. Thus, the high success rates associated with these devices have led to their increased adoption rate among end-users and limited the use of antihypertensive drugs to a certain extent among patients, thereby restricting market growth.
This antihypertensive drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global antihypertensive drugs market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the antihypertensive drugs market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the antihypertensive drugs market encompasses successful business strategies deployed by the key vendors. The antihypertensive drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The antihypertensive drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the antihypertensive drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
41% of the market’s growth will originate from North America during the forecast period. The US is the key market for the antihypertensive drugs market in North America. Market growth in this region will be slower than the growth of the market in Asia.
Rising awareness among people about hypertension will facilitate the antihypertensive drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 negatively affected regional market growth. However, by the second half of 2020, lockdown-related restrictions were somewhat relaxed in various countries, which allowed the movement of people outside their homes. Thus, the regional market will register growth during the forecast period.
To gain further insights on the market contribution of various segments Request PDF Sample
The antihypertensive drugs market share growth by the systemic hypertension segment will be significant during the forecast period. The direct arterial dilator and direct venous dilator are also used for the treatment of patients with systemic hypertension. Moreover, centrally acting drugs that include clonidine, guanabenz, guanfacine, and Alpha-methyldopa are used to decrease sympathetic autonomic outflow for the reduction of systemic vascular resistance and cardiac output in patients with hypertension. All these specific treatments are expected to treat patients with systemic hypertension and drive the growth of the segment.
This report provides an accurate prediction of the contribution of all the segments to the growth of the antihypertensive drugs market size and actionable market insights on post COVID-19 impact on each segment.
Antihypertensive Drugs Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.1% |
Market growth 2022-2026 |
$ 5.87 billion |
Market structure |
Fragmented |
YoY growth (%) |
2.5 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key consumer countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Co Inc, Bayer AG, Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson, Lupin Ltd, Merck and Co. Inc., Noden Pharma DAC, Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc., and Zydus Lifesciences Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.